Retrospective review of safety and efficacy of programmed cell death-1 inhibitors in refractory high grade gliomas

Overview of attention for article published in Journal for Immunotherapy of Cancer, December 2017

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (73rd percentile)

Mentioned by

twitter: 11 X users

Citations

dimensions_citation: 55 Dimensions

Readers on

mendeley: 66 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 25 X posts from 11 X users, with an upper bound of 37,430 followers.

RT @radonconeuro: #elderly #gliomas Retrospective review of safety and efficacy of programmed cell death-1 inhibitors in refractory high gr…

30 Aug 2018

Reply Repost Favourite

#elderly #gliomas Retrospective review of safety and efficacy of programmed cell death-1 inhibitors in refractory high grade gliomas. https://t.co/PBvBcTAMYR

30 Aug 2018

Reply Repost Favourite

@SherryAske @Mevcsncer3 @PaulDewar I like the focus. Are you serious about reporting on treatments for glioblastoma? This trial has already been performed, https://t.co/3xVenjatsJ.

20 Aug 2018

Reply Repost Favourite

Retrospective review of safety and efficacy of programmed cell death-1 inhibitors in refractory high grade gliomas https://t.co/L43Ojz3BqF

18 Aug 2018

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 21 additional X posts.